How Effective Is Pharmacovigilance? EMA Committee Intends To Find Out
This article was originally published in The Pink Sheet Daily
Executive Summary
'Impact studies' will allow regulators to determine which activities are successful and which are not.
You may also be interested in...
EU Drug Safety Actions Speeded Up By New Legislation, Says Commission
The European Commission reports that new regulatory tools made available under the revised pharmacovigilance legislation have allowed drug safety issues to be detected and acted upon more rapidly, and that further improvements to the system are in the pipeline.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.